Search Within

Marc Ladanyi

  1. "Lung Cancer"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (2)
Groups
  1. Department of Pathology and Laboratory Medicine (8)
  2. GSK Faculty (8)
  3. Human Oncology and Pathogenesis Program (8)
  4. Tow Center for Developmental Oncology (TCDO) (8)
  5. Surgery (5)
  6. Department of Medicine (2)

More Groups

People
  1. Valerie Rusch (5)
  2. Maureen Zakowski (3)
  3. Adam Olshen (2)
  4. Mark Kris (2)
  5. Shigeki Shimizu (2)
  6. William Pao (2)

More People

Years
  1. 2011 (1)
  2. 2006 (3)
  3. 2005 (4)
Publications
  1. Lung Cancer (8)
Publishers
  1. Elsevier Ireland Ltd. (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors
    Journal Article

    Brevet, M.; Johnson, M. L.; Azzoli, C. G.; Ladanyi, M.
    Lung Cancer (2011)

    Fulltext@MSK | Save
  • An integrated genomic approach to understanding the determinants of mesotheliorna sensitivity to specific novel agents
    Meeting Abstract

    Shimizu, S.; Olshen, A. B.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • MET in mesothelioma: Mutational screening, phosphorylation status, and sensitivity to the MET inhibitor PHA-665752
    Meeting Abstract

    Shimizu, S.; Krug, L.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • Debate: SV40 as a significant carcinogen in human mesothelioma and other cancers: An increasingly dubious hypothesis
    Meeting Abstract

    Ladanyi, M.
    Lung Cancer (2006)

    Fulltext@MSK | Save
  • EGFR and KRAS mutational analysis of mucinous pneumonic bronchiololavelolar carcinomas
    Meeting Abstract

    Zakowski, M.; Ladanyi, M.; Kris, M.; Rusch, V.; Pao, W.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC
    Meeting Abstract

    Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Gene expression profiling of malignant mesothelioma for prognostic prediction and identification of potential therapeutic targets and differential diagnostic markers
    Meeting Abstract

    Lopez-Rios, F.; Chuai, S.; Hussain, S.; Szoke, J.; Gerald, W.; Zakowski, M.; Olshen, A.; Flores, R.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Implications of P16/CDKN2A deletion in pleural mesotheliomas
    Journal Article

    Ladanyi, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save